"Other children didn't want to sit next to me,' " Amit Ghose, an advocate for people with visible differences, shared ...

Nearly one million Americans are living with Parkinson’s disease, a progressive neurological disorder affecting movement and ...

“Think of it like charging your phone,” Motif co-founder and CEO Jacob Robinson told STAT’s O. Rose Broderick. Read their ...

There’s an awareness walk coming up this weekend deals with a disease that steals mobility, memory and so much more from its ...

When Sian Elvin was diagnosed with coeliac disease, she was worried about how she could still travel – but a trip to the ...

South Carolina’s measles outbreak — the worst in the U.S. in more than 35 years — is over, state health officials declared Monday. On Sunday, the state passed the threshold of 42 days with no new ...

April 27 (Reuters) - Intellia Therapeutics said on Monday its experimental therapy for a rare genetic disorder has met the main goal in a late-stage study. The therapy lonvoguran ziclumeran is aimed ...

Researchers at UC San Diego say they recently uncovered new insights into a protein that has emerged as a potential molecular “switch” that may determine whether Alzheimer’s-like brain changes lead to ...

By Kunal Das and Kamal Choudhury April 27 (Reuters) - Intellia Therapeutics said on Monday its experimental gene-editing therapy reduced the frequency of swelling attacks in patients with a rare ...

Police have released images of 11 people they would like to speak to following disorder at a derby match between Portsmouth ...

In its SEC prospectus, Hemab says it intends to use the net proceeds, together with existing cash, to fund clinical ...

The U.S. Food and Drug Administration granted Priority Review to Johnson & Johnson’s (NYSE:JNJ) supplemental biologics license application for IMAAVY (nipocalimab-aahu) as a treatment for warm ...